Demonstrates a novel no-reference quality assessment for dermoscopic images, suggesting improved diagnostic reliability.
Background: Assessing image quality is critical in medical imaging to ensure diagnostic reliability. Traditional no-reference image quality assessment (IQA) metrics designed for natural images often fail to address the complexities of medical images. This study proposes DermaIQA, a novel no-reference metric for dermoscopic images that aligns quality scores with clinical perception. Methods: We developed a degradation pipeline simulating realistic artifacts without requiring extensive manual labeling. From 812 expert-classified images, we generated a comprehensive dataset (>125,000 images) using controlled blur and compression techniques. An iterative ranking procedure converted these degradations into a continuous quality scale, which was used to train a vision transformer model. Results: The proposed IQA metric outperformed both heuristic and deep learning techniques, achieving 92% accuracy in distinguishing high-quality vs. low-quality images. The approach demonstrated robust generalization when tested on external datasets with different acquisition characteristics, confirming its relevance across varied imaging conditions. Conclusions: DermaIQA represents the first dermatology-specific quality metric that minimizes expert annotation requirements while maintaining clinical relevance. This tool enhances workflows through real-time acquisition feedback and acts as a gatekeeper for AI diagnostic systems, ensuring only high-quality images are processed. The trained model and inference scripts are publicly available.
No takes yet. Share an insight, caveat, or question.
Ferraris et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: